FCGR3A and hematologic disorder: Given the importance of ADCC induction for the efficacy of antitumor mAb, particularly in hematological malignancies [6,7], many efforts presently aim to increase the efficacy of antitumor mAb by enhancing the affinity of the Fc part to CD16a expressed, e.g., on NK cells and thus improve ADCC.